MSB 2.51% 97.0¢ mesoblast limited

Mesoblast Remains on Track, Clinical Trial Readouts Still Ahead, page-3

  1. 3,346 Posts.
    lightbulb Created with Sketch. 269
    Not directed at you Jack, just a generic question to all the lovers of informed advice.....

    WTF would an analyst from morning know about the prospects of MSB. I mean, they're not even a GP from New Zealand and we all known GPs have absolutely NFI about MSB
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.